Package 71610-976-60

{"route": ["ORAL"], "spl_id": "463bbc40-763f-4ba5-e063-6394a90a1352", "openfda": {"nui": ["N0000175729", "N0000175651", "N0000175769"], "unii": ["R3UK8X3U3D"], "rxcui": ["260218"], "spl_set_id": ["463bb960-a0b5-4ca4-e063-6294a90a683b"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]"], "pharm_class_epc": ["Sympathomimetic-like Agent [EPC]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71610-976-30)", "package_ndc": "71610-976-30", "marketing_start_date": "20251217"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71610-976-53)", "package_ndc": "71610-976-53", "marketing_start_date": "20251217"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71610-976-60)", "package_ndc": "71610-976-60", "marketing_start_date": "20251217"}], "brand_name": "Modafinil", "product_id": "71610-976_463bbc40-763f-4ba5-e063-6394a90a1352", "dosage_form": "TABLET", "pharm_class": ["Central Nervous System Stimulation [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic-like Agent [EPC]"], "product_ndc": "71610-976", "dea_schedule": "CIV", "generic_name": "Modafinil", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Modafinil", "active_ingredients": [{"name": "MODAFINIL", "strength": "100 mg/1"}], "application_number": "ANDA209966", "marketing_category": "ANDA", "marketing_start_date": "20190215", "listing_expiration_date": "20261231"}